- DNA X, Inc. completed the sale of its mobile device assets to NEXA for $15 million in January 2026.
- The transaction generated $6.3 million in net income for the first quarter of 2026, and proceeds are being used to repay debt and support the AI trading business.
- The company plans to launch an enhanced version of its AI trading platform later this year, aiming for sustainable long-term growth in the decentralized crypto sector.
- U.S. pre-market trading shows significant activity, with DNA X up 9.82%, though no major news explains this volatility.
- Adobe sees a pre-market increase of 3.12% following a $25 billion buyback announcement and the launch of AI tools, despite a 30% drop in its stock this year.
- Axe Compute leads with a 154.35% gain, attributed to internal confidence from executives and strategic developments in AI, while Inhibrx rises 30.83% due to interest in its cancer drug linked to strong trial data.